Evidence map›Paper›PMID 29330826›Full record

ArticleJournal of neurovirology2018

Antibody response to polyomavirus primary infection: high seroprevalence of Merkel cell polyomavirus and lymphoid tissue involvement.

Carolina Cason, Lorenzo Monasta, Nunzia Zanotta, Giuseppina Campisciano, Iva Maestri, Massimo Tommasino, Michael Pawlita, Sonia Villani, Manola Comar, Serena Delbue

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of neurovirology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. BK polyomavirus in a Portuguese healthy group: seroprevalence, viral Excretion, and implications for transmission pathways.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Carolina CasonDepartment of Medical Sciences, University of Trieste, Piazzale Europa 1, 34127, Trieste, Italy.
Lorenzo MonastaInstitute for Maternal and Child Health-IRCCS "Burlo Garofolo", Via dell' Istria 65/1, 34137, Trieste, Italy.
Nunzia ZanottaInstitute for Maternal and Child Health-IRCCS "Burlo Garofolo", Via dell' Istria 65/1, 34137, Trieste, Italy.
Giuseppina CampiscianoInstitute for Maternal and Child Health-IRCCS "Burlo Garofolo", Via dell' Istria 65/1, 34137, Trieste, Italy.
Iva MaestriDepartment of Experimental and Diagnostic Medicine, Pathology Unit of Pathologic AnatomyHistology and Cytology University of Ferrara, Via Luigi Borsari 46, 44121, Ferrara, Italy.
Massimo TommasinoInfections and Cancer Biology Group, International Agency for Research on Cancer, Cours Albert Thomas 150, 69372, Lyon, France.
Michael PawlitaGerman Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Sonia VillaniDepartment of Biomedical, Surgical & Dental Sciences, University of Milano, Via Pascal 36, 20100, Milan, Italy.
Manola ComarDepartment of Medical Sciences, University of Trieste, Piazzale Europa 1, 34127, Trieste, Italy.
Serena DelbueDepartment of Biomedical, Surgical & Dental Sciences, University of Milano, Via Pascal 36, 20100, Milan, Italy. serena.delbue@unimi.it.ORCID 0000-0002-3199-9369
IRCCS Materno Infantile Burlo Garofolo · ITUniversity of Milan · ITUniversity of Trieste · ITCentre international de recherche sur le cancer · FRGerman Cancer Research Center · DEUniversity of Ferrara · IT

Funding

World Health Organization 001
6 · The paper itself

Abstract

Human polyomaviruses (HPyVs) asymptomatically infect the human population establishing latency in the host, and their seroprevalence can reach 90% in healthy adults. Few studies have focused on the pediatric population, and there are no reports regarding the seroprevalence of all the newly isolated HPyVs among Italian children. Therefore, we investigated the frequency of serum antibodies against 12 PyVs in 182 immunocompetent children from Northeast Italy, by means of a multiplex antibody detection system. Additionally, secondary lymphoid tissues were collected to analyze the presence of HPyV DNA sequences using a specific real-time PCRs or PCRs. Almost 100% of subjects were seropositive for at least one PyV. Seropositivity ranged from 3% for antibodies against simian virus 40 (SV40) in children from 0 to 3 years, to 91% for antibodies against WU polyomavirus (WUPyV) and HPyV10 in children from 8 to 17 years. The mean number of PyV for which children were seropositive increased with the increasing of age: 4 standard deviations (SD) 1.8 in the 0-3-year group, 5 (SD 1.9) in the 4-7-year group, and 6 (SD 2.2) in the 8-17-year group. JC polyomavirus (JCPyV) DNA was detected in 1% of the adenoids, WUPyV in 12% of the tonsils, and 28% of the adenoids, and Merkel cell polyomavirus (MCPyV) was present in 6 and 2% of the tonsils and adenoids, respectively. Our study gives new insights on the serological evidence of exposure to PyVs during childhood, and on their possible respiratory route of transmission.

Indexed as

AdenoidsAdolescentAntibodies, ViralChildChild, PreschoolFemaleHumansImmunocompetenceInfantInfant, NewbornItalyMaleMerkel cell polyomavirusPalatine TonsilPolyomavirus InfectionsSeroepidemiologic StudiesAntibodies, ViralLymphoid tissuesMCPyVPolyomavirusesSeroprevalence

Identifiers

PMID29330826
OpenAlexW2783003040

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.